-- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib (IBRANCE®) -- NEW HAVEN, Conn. and NEW...
New York, USA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Triple-Negative Breast Cancer Market to Grow Rapidly During the Forecast Period (2023–2032), Predicts DelveInsight | Key...
Merck & Co Inc (NYSE: MRK) released results from the STRIDE-3 Phase 3 trial evaluating V116, the company's investigational 21-valent pneumococcal conjugate vaccine. The trial...
Eli Lilly (NYSE:LLY)'s recent foray into the weight-loss market with the approval of its diabetes drug Mounjaro for weight management signals a strategic expansion for the...
NEW YORK - Bristol Myers (NYSE:BMY) Squibb Co. (NYSE:BMY) experienced a downturn on Thursday, ending a two-day streak of gains as its shares dropped 1.42% to close at $50.84. The...
In a high-profile gathering in San Francisco, Chinese President Xi Jinping is hosting an exclusive dinner with top US business leaders, including Apple (NASDAQ:AAPL)'s Tim Cook and...
NEW YORK - Pfizer Inc. (NYSE:PFE) has announced a significant workforce reduction at its Sandwich, Kent, U.K. facility, impacting 500 employees, primarily scientists, as the...
Astellas Pharma Inc. and Pfizer Inc. (PFE) today announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug...
In a recent breakthrough for Eli Lilly and Company (NYSE:LLY), its new weight loss drug, Zepbound, received approval from the Food and Drug Administration (FDA) on Wednesday. The...